Anti-muscarinic actions of mitoxantrone in isolated heart muscles of guinea pigs

European Journal of Pharmacology

Volumn 407, Issue 1-2, 2000, Pages 183-189

  Chugun, Akihito ^a   Uchide, Tsuyosi ^a   Fujimori, Yuki ^a   Temma, Kyosuke ^a   Hara, Yukio ^a   Sasaki, Takushi ^a   Akera, Tai ^b  

^a KITASATO UNIVERSITY   (Japan)

^b Merck Sharp Dohm Res Labs Japan   (Japan)

Author keywords

Anti muscarinic action; Guinea pig; Heart; Mitoxantrone

Indexed keywords

CARBACHOL; MITOXANTRONE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINUCLIDINYL BENZILATE;

ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; GUINEA PIG; IC 50; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS; ANIMAL; CARBACHOL; CHOLINERGIC AGONISTS; DEPRESSION, CHEMICAL; GUINEA PIGS; HEART ATRIUM; HEART VENTRICLE; MALE; MITOXANTRONE; MUSCARINIC ANTAGONISTS; MYOCARDIAL CONTRACTION; QUINUCLIDINYL BENZILATE; RECEPTORS, MUSCARINIC; STIMULATION, CHEMICAL;

EID: 0034722002     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00729-9     Document Type: Article

References (29)

1. Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model
2. Rationale for the use of mitoxantrone in the older patient: cardiac toxicity
3. Clinical evaluation of adriamycin, a new antitumor antibiotic
4. Atropine, scopolamine, and related antimuscarinic drugs
5. Doxorubicin-induced cardiac toxicity
6. Mitoxantrone, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer
7. Adriamycin and the heart
8. Safety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin: 1. Clinical observations
9. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer
10. Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the Fe(III)-mitoxantrone complex
11. Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum
12. Allosteric modulators of ligand binding to muscarinic acetylcholine receptors
13. Anthracycline cardiomyopathy: predictive value of animal models
14. The human tumor clonogenic assay in human breast cancer
15. ++ release channels of rat cardiac sarcoplasmic reticulum: evidence for a competitive mechanism
16. + channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins
17. Neural regulation of the heart beat
18. Antitumor agents: 1. 1,4-bis[(aminoalkyl)amino]-9, 10-anthracenediones
19. Myocardial effects of mitoxantrone and doxorubicin in the mouse and guinea pig
20. Potential cardiotoxicity with mitoxantrone
21. Accidental overdose of mitoxantrone in three patients
22. Subcellular effects of adriamycin in the heart: a concise review
23. Safety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin: II. Histologic and ultrastructural pathology
24. Doxorubicin: an antagonist of muscarinic receptors in guinea pig heart
25. Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart
26. Anti-muscarinic action of mitoxantrone in guinea pig hearts
27. Cardiac evaluation of mitoxantrone
28. Activity of a novel anthracenedione, 1, 4-dihydroxy-5, 8-bis{{{2-[(2-hydroxyethyl)amino]ethyl}amino}}-9, 10-anthracenedione dihydrochloride, against experimental tumors in mice
29. Effects of mitoxantrone on action potential and membrane currents in isolated cardiac myocytes